BioGenex designs, develops and commercializes molecular pathology systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology.
To Enable Pathologists and Clinicians for Precise Diagnosis and Improved life of Cancer Patient. This is reflected in:
Productivity & Service
Meeting or exceeding internal and external customer needs
Quality & Reliability
Meeting or exceeding international (ISO) quality standards and country-specific regulatory requirements
Quality by design (QbD) and continuous improvement implemented by our employees
Our core values
We “do the right thing” and believe in being responsive, straight-forward and committed to our customers.
Our Team: Driving Global Success
At Biogenex, we owe our remarkable achievements to the collective brilliance and dedication of our diverse team, spanning across the globe. With over 250 exceptional individuals working tirelessly towards a shared vision, we are at the forefront of innovation and excellence in [industry/field]
The Biogenex history
BioGenex is a global market leader in molecular pathology providing customer-centric solutions for complete automation of cell and tissue staining. Through proprietary cutting-edge technologies, the company has transformed the practice of slide-based staining performed in modern molecular pathology laboratories.
The first steps
Company founded in San Ramon, California by Dr. Krishan Kalra & Satya Kalra
Introduction of BioGenex antigen retrieval products
Introduction of MultiLink IHC detection system
BioGenex acquired American Bionetics (ABN) and turned their DNA/RNA reagent business into a profitable venture within six months.
Introduction of DNA probe product line for in situ hybridization, and Introduction of first generation of OptiMax Plus staining system
Introduction of Advanced OptiMax Plus staining system
Introduction of special stain kits to OptiMax Plus staining system
Introduction of i6000™ staining system
BioGenex entered agreement with Abbott to co-develop FISH automation
Introduction of Xmatrx® staining system, and introduction of Super Sensitive Polymer-HRP detection system
Hyderabad, India subsidiary established
Introduction of eFISHiency, fully automated FISH system powered by Abbot. Abbott and BioGenex extended Xmatrx® technology co-development and distribution agreement
Agency office open in Shanghai, China
Introduction of multiple Nucleic Acid Detection (NAD) products, and Introduction of Xmatrx® ELITE, NANO and MINI systems
Global Expansion & BioGenex Automation
Dedication of 100,000 sq.ft. Regional Center of Excellence in Hyderabad, India. Xmatrx® offered in situ PCR and miRNA assays
Introducing Xmatrx Elite, Nano & Mini
Business Expansion Planning
Xmatrx Ultra, NanoMatrx, NanoMatrx Rx, NanoMatrx Dx
COVID 19 – Viral Transport Medium, RT-PCR kit
New Improved Poly HRP Kits
Satisfied Customers Speak Out
Xmatrx Infinity Enables Automated FISH for Physical Mapping of Chromosomes About Dr. Sharakhov Igor Sharakhov Ph.D., is an Associate Professor with the Department of Entomology at Virginia Tech focusing on comparative genomics and molecular genetics of malaria mosquitoes.
We have been using BioGenex NanoVIP all-in-one fully automated staining system for the last 2 years. It enables automation of any slide-based staining procedures (baking to DAPI mounting), in our lab, we use it for in situ hybridization (ISH)/RNAScope.